Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Pulse Biosciences, Inc. | plse-20191231xex32_1.htm |
| EX-31.2 - EX-31.2 - Pulse Biosciences, Inc. | plse-20191231xex31_2.htm |
| EX-31.1 - EX-31.1 - Pulse Biosciences, Inc. | plse-20191231xex31_1.htm |
| EX-23.1 - EX-23.1 - Pulse Biosciences, Inc. | plse-20191231xex23_1.htm |
| EX-21.1 - EX-21.1 - Pulse Biosciences, Inc. | plse-20191231xex21_1.htm |
| EX-10.20 - EX-10.20 - Pulse Biosciences, Inc. | plse-20191231xex10_20.htm |
| EX-4.6 - EX-4.6 - Pulse Biosciences, Inc. | plse-20191231xex4_6.htm |
| 10-K - 10-K - Pulse Biosciences, Inc. | plse-20191231x10k.htm |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement Nos. 333-227974, 333-224800, 333-219104 and 333-219096 on Form S-3 and Nos. 333-229320, 333-222582, 333-221788, 333-218164, and 333-216897 on Form S-8 of our report dated March 16, 2020, relating to the financial statements of Pulse Biosciences, Inc. and its subsidiaries appearing in this Annual Report on Form 10-K of Pulse Biosciences, Inc. for the year ended December 31, 2019.
/s/ DELOITTE & TOUCHE LLP
San Jose, California
March 16, 2020